Updated analysis of a phase II study (20060314) of panitumumab (pmab) with FOLFIRI as first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC)
- Publication date
- 1 January 2009
- Publisher
- 'American Society of Clinical Oncology (ASCO)'